PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Competition???, page-48

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    If I were a generic manufacturer, I'd easily decide that there must be easier drugs to copy after watching that video. It'll cost 10's of millions just to attempt to make a generic, not to mention that there is a high probability that they will simply fail.
    Last edited by Zenox: 10/10/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.